title: Semax corrects brain dysfunction caused by prenatal introduction of valproic acid.
authors.affiliation: Biological Faculty, Moscow State University, Moscow, Russia.
authors.forename: A V
authors.initials: AV
authors.lastname: Malyshev
authors.forename: E V
authors.initials: EV
authors.lastname: Razumkina
authors.forename: V A
authors.initials: VA
authors.lastname: Dubynin
authors.forename: N F
authors.initials: NF
authors.lastname: Myasoedov
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology; D000818:Animals; D000831:Animals, Newborn; D000927:Anticonvulsants / Q000009:adverse effects* / Q000494:pharmacology; D001927:Brain Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D005260:Female; D008297:Male; D018696:Neuroprotective Agents / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects / Q000139:chemically induced / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology; D051381:Rats; D014635:Valproic Acid / Q000009:adverse effects* / Q000494:pharmacology
chemical_list: D000927:Anticonvulsants; D018696:Neuroprotective Agents; D010446:Peptide Fragments; D014635:Valproic Acid; C048487:ACTH (4-7), Pro-Gly-Pro-; D000324:Adrenocorticotropic Hormone